Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling

BACKGROUND: Glioblastoma (GBM) is a lethal type of primary brain tumor with a median survival less than 15 months. Despite the recent improvements of comprehensive strategies, the outcomes for GBM patients remain dismal. Accumulating evidence indicates that rapid acquired chemoresistance is the majo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Alafate, Wahafu, Xu, Dongze, Wu, Wei, Xiang, Jianyang, Ma, Xudong, Xie, Wanfu, Bai, Xiaobin, Wang, Maode, Wang, Jia
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657349/
https://ncbi.nlm.nih.gov/pubmed/33176854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01750-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados